Oscar Health (NYSE:OSCR) Posts Earnings Results, Beats Expectations By $0.04 EPS

Oscar Health (NYSE:OSCRGet Rating) issued its earnings results on Tuesday. The company reported ($0.36) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.40) by $0.04, MarketWatch Earnings reports. Oscar Health had a negative net margin of 31.11% and a negative return on equity of 35.39%. During the same quarter last year, the company earned ($0.98) earnings per share.

Shares of Oscar Health stock opened at $5.94 on Thursday. The company has a 50-day simple moving average of $8.41 and a two-hundred day simple moving average of $8.85. The company has a market capitalization of $1.24 billion, a PE ratio of -1.80 and a beta of 0.75. Oscar Health has a one year low of $5.72 and a one year high of $29.70.

OSCR has been the subject of a number of research reports. Zacks Investment Research raised shares of Oscar Health from a “hold” rating to a “buy” rating and set a $9.50 price objective for the company in a research note on Thursday, April 14th. Morgan Stanley lowered their price objective on shares of Oscar Health from $20.00 to $18.00 and set an “overweight” rating for the company in a research note on Monday, March 28th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $11.33.

In other news, EVP Alessandrea C. Quane sold 49,355 shares of Oscar Health stock in a transaction on Wednesday, February 16th. The shares were sold at an average price of $7.18, for a total transaction of $354,368.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Richard Scott Blackley sold 19,204 shares of Oscar Health stock in a transaction on Tuesday, March 8th. The stock was sold at an average price of $7.33, for a total transaction of $140,765.32. The disclosure for this sale can be found here. Insiders have sold 89,912 shares of company stock valued at $658,944 over the last quarter.

Large investors have recently bought and sold shares of the company. Thrive Capital Management LLC lifted its position in Oscar Health by 14.5% during the third quarter. Thrive Capital Management LLC now owns 37,614,286 shares of the company’s stock valued at $654,112,000 after purchasing an additional 4,755,222 shares during the period. Morgan Stanley lifted its position in Oscar Health by 67.8% during the second quarter. Morgan Stanley now owns 916,917 shares of the company’s stock valued at $19,714,000 after purchasing an additional 370,639 shares during the period. BlackRock Inc. lifted its position in Oscar Health by 17.0% during the fourth quarter. BlackRock Inc. now owns 715,585 shares of the company’s stock valued at $5,617,000 after purchasing an additional 104,129 shares during the period. Wells Fargo & Company MN lifted its position in Oscar Health by 62.0% during the fourth quarter. Wells Fargo & Company MN now owns 336,078 shares of the company’s stock valued at $2,639,000 after purchasing an additional 128,684 shares during the period. Finally, Millennium Management LLC lifted its position in Oscar Health by 455.6% during the fourth quarter. Millennium Management LLC now owns 288,391 shares of the company’s stock valued at $2,264,000 after purchasing an additional 236,486 shares during the period. Institutional investors and hedge funds own 98.65% of the company’s stock.

About Oscar Health (Get Rating)

Oscar Health, Inc provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients.

See Also

Earnings History for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.